Nemaura Medical Inc. (NMRD)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 14.56 Million USD | -34.11% |
| 2022 | 22.1 Million USD | -37.29% |
| 2021 | 35.24 Million USD | 2788.71% |
| 2020 | 1.22 Million USD | -74.39% |
| 2019 | 4.76 Million USD | -23.85% |
| 2018 | 6.25 Million USD | -15.49% |
| 2017 | 7.4 Million USD | -23.95% |
| 2016 | 9.73 Million USD | 965.9% |
| 2015 | 913.1 Thousand USD | -55.45% |
| 2014 | 2.04 Million USD | 694.09% |
| 2013 | 258.12 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 8.45 Million USD | -41.98% |
| 2024 Q3 | 5.16 Million USD | -42.04% |
| 2024 Q2 | 8.91 Million USD | 5.55% |
| 2023 FY | 14.56 Million USD | -34.11% |
| 2023 Q3 | 12.96 Million USD | -18.49% |
| 2023 Q1 | 19.71 Million USD | -10.8% |
| 2023 Q4 | 14.56 Million USD | 12.36% |
| 2023 Q2 | 15.9 Million USD | -19.34% |
| 2022 Q1 | 35.68 Million USD | 1.25% |
| 2022 Q4 | 22.1 Million USD | -18.36% |
| 2022 FY | 22.1 Million USD | -37.29% |
| 2022 Q3 | 27.07 Million USD | -14.31% |
| 2022 Q2 | 31.59 Million USD | -11.46% |
| 2021 Q3 | 17.63 Million USD | -2.6% |
| 2021 Q4 | 35.24 Million USD | 99.8% |
| 2021 Q1 | 8.91 Million USD | 631.0% |
| 2021 Q2 | 18.1 Million USD | 103.05% |
| 2021 FY | 35.24 Million USD | 2788.71% |
| 2020 FY | 1.22 Million USD | -74.39% |
| 2020 Q4 | 1.22 Million USD | -43.61% |
| 2020 Q1 | 3.97 Million USD | -16.54% |
| 2020 Q2 | 2.7 Million USD | -31.99% |
| 2020 Q3 | 2.16 Million USD | -19.97% |
| 2019 Q3 | 5.74 Million USD | 31.16% |
| 2019 Q4 | 4.76 Million USD | -17.13% |
| 2019 Q1 | 5.57 Million USD | -10.92% |
| 2019 Q2 | 4.38 Million USD | -21.34% |
| 2019 FY | 4.76 Million USD | -23.85% |
| 2018 Q1 | 7.4 Million USD | 0.06% |
| 2018 Q2 | 6.99 Million USD | -5.55% |
| 2018 Q3 | 6.8 Million USD | -2.76% |
| 2018 Q4 | 6.25 Million USD | -8.04% |
| 2018 FY | 6.25 Million USD | -15.49% |
| 2017 Q4 | 7.4 Million USD | -5.85% |
| 2017 FY | 7.4 Million USD | -23.95% |
| 2017 Q3 | 7.86 Million USD | -8.48% |
| 2017 Q2 | 8.59 Million USD | -2.35% |
| 2017 Q1 | 8.79 Million USD | -9.61% |
| 2016 Q4 | 9.73 Million USD | -3.65% |
| 2016 Q2 | 379.56 Thousand USD | -31.22% |
| 2016 Q3 | 10.1 Million USD | 2561.44% |
| 2016 Q1 | 551.85 Thousand USD | -39.56% |
| 2016 FY | 9.73 Million USD | 965.9% |
| 2015 Q2 | 1.56 Million USD | -17.79% |
| 2015 FY | 913.1 Thousand USD | -55.45% |
| 2015 Q3 | 1.24 Million USD | -20.74% |
| 2015 Q4 | 913.1 Thousand USD | -26.41% |
| 2015 Q1 | 1.9 Million USD | -7.1% |
| 2014 Q3 | 81.01 Thousand USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q4 | 2.04 Million USD | 2430.02% |
| 2014 FY | 2.04 Million USD | 694.09% |
| 2013 FY | 258.12 Thousand USD | 0.0% |
| 2013 Q4 | 258.12 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acutus Medical, Inc. | 53.96 Million USD | 73.011% |
| Biotricity, Inc. | 5.94 Million USD | -145.064% |
| Cell MedX Corp. | 46.12 Thousand USD | -31475.459% |
| Dynatronics Corporation | 25.94 Million USD | 43.859% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -367.482% |
| RetinalGenix Technologies Inc. | 156.00 USD | -9335305.769% |
| Sonendo, Inc. | 78.16 Million USD | 81.367% |
| Telesis Bio, Inc. | 70.41 Million USD | 79.317% |
| Talis Biomedical Corporation | 98.34 Million USD | 85.191% |
| Viveve Medical, Inc. | 25.91 Million USD | 43.8% |